Account
Inquiry
Tirzepatide (CAS 2023788-19-2) is a dual GIP and GLP-1 receptor agonist primarily used in diabetes research. This innovative compound demonstrates significant potential in glucose regulation and weight management studies.
Our pharmaceutical-grade Tirzepatide is manufactured under strict quality control measures, ensuring consistent 99% purity for research applications. The product is supplied in sterile vials with various dosage options to meet different experimental requirements.
Key research applications include metabolic disorder studies, weight management research, and diabetes treatment development. The compound's unique dual-action mechanism makes it particularly valuable for investigating new therapeutic approaches.
For research institutions and pharmaceutical developers looking to buy Tirzepatide, we offer flexible ordering options including bulk quantities and custom formulations. Our production facility maintains GMP standards to ensure product consistency and reliability.
Important Note: This product is intended for research purposes only and not for human consumption. Proper handling procedures should be followed by qualified researchers in controlled laboratory environments.
